Difference between revisions of "Team:NTU-LIHPAO-Taiwan/Modeling/Conclusion"
LesleyChiu (Talk | contribs) |
LesleyChiu (Talk | contribs) |
||
| Line 803: | Line 803: | ||
<span class="title">Modeling Summary</span> | <span class="title">Modeling Summary</span> | ||
<ul class="sub-Content"> | <ul class="sub-Content"> | ||
| − | <li><a href="# | + | <li><a href="#First1">Hypothesis</a></li> |
| − | <li><a href="# | + | <li><a href="#First2">Conclusion</a></li> |
</ul> | </ul> | ||
Revision as of 19:25, 12 September 2015
- Modeling Summary
- Main Part
- Test Part
- Reference
Modeling Summary
Hypothesis
After orally ingested, certain amounts of modified probiotic L. casei can survive under acidic condition when passing through the stomach. Owning to gastric acid, bile acid and digestive enzymes, the presence of these bacteria in the intestinal tract only last for a limited time, and then are washed out in faeces.[1] During the process of transition and temporary colonization, CPP-PYY complexes are produced and exert the following effect.
Conclusion
Ideally, the optimal concentration of PYY is 0.1 μg/L for appetite suppression, giving little side effect. Here we performed the simulation with 109 of total L. casei intake, and 10-10 μg/min of CPP-PYY complex production rate per L. casei. The results is shown below.
By building the model for simulation step by step, we summarized the general formula with varies parameters to determine the dose response :
[Final concentration of PYY in the blood (μg/L)] = 11745 × [Total L. casei intake] × [Distribution ratio of L. casei] × [CPP-PYY complex production rate per L. casei (μg/min)]
This general formula is based on one-dose response, and continuous drug intake should be further modified by successive accumulation for determining the appetite suppression effect.
Maintained by the iGEM team NTU-LIHPAO-Taiwan ©2015 NTU-LIHPAO-Taiwan